Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice

Journal of Nutritional Biochemistry

Volumn 50, Issue , 2017, Pages 16-25

  Bagarolli, Renata A ^a   Tobar, Natália ^a   Oliveira, Alexandre G ^b   Araújo, Tiago G ^a   Carvalho, Bruno M ^c   Rocha, Guilherme Z ^a   Vecina, Juliana F ^a   Calisto, Kelly ^a   Guadagnini, Dioze ^a   Prada, Patrícia O ^a   Santos, Andrey ^a   Saad, Sara T O ^a   Saad, Mario J A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Gut microbiota; Insulin sensitivity; Probiotics

Indexed keywords

BACTERIAL DNA; BACTERIUM LIPOPOLYSACCHARIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; JANUS KINASE 2; LEPTIN; MYELOID DIFFERENTIATION FACTOR 88; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ACTINOBACTERIA; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; BIFIDOBACTERIUM BIFIDUM; CONTROLLED STUDY; DIET INDUCED OBESITY; FECES ANALYSIS; FIRMICUTES; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERPHAGIA; HYPOTHALAMIC TISSUE; ILEUM TISSUE; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SIGNALING; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACHNOSPIRACEAE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; LIPID DIET; LIVER HISTOLOGY; LIVER TISSUE; MALE; METAGENOME; MOUSE; MUSCLE TISSUE; NONHUMAN; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RIMINOCOCCUS; ROBINSONIELLA; WESTERN BLOTTING; ANIMAL; CELL MEMBRANE PERMEABILITY; CLASSIFICATION; DIET THERAPY; DYSBIOSIS; FECES; GLUCOSE CLAMP TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; LIVER; METABOLISM; MICROBIOLOGY; MOLECULAR TYPING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; APPETITE REGULATION; BIFIDOBACTERIUM BIFIDUM; CELL MEMBRANE PERMEABILITY; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DYSBIOSIS; FECES; GASTROINTESTINAL MICROBIOME; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; INTESTINAL MUCOSA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; LIVER; MALE; MICE; MOLECULAR TYPING; OBESITY; PROBIOTICS; RANDOM ALLOCATION;

EID: 85030094537     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2017.08.006     Document Type: Article

References (66)

1. Kahn, S.E., Hull, R.L., Utzschneider, K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:7121 (2006), 840–846.
2. Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu Rev Immunol 29 (2011), 415–445.
3. Saad, M.J., Santos, A., Prada, P.O., Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda) 31:4 (2016), 283–293.
4. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez-Humaran, L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 3:9 (2011), 559–572.
5. Aronsson, L., Huang, Y., Parini, P., Korach-Andre, M., Hakansson, J., Gustafsson, J.A., et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5:9 (2010), 1–7.
6. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:7 (2007), 1761–1772.
7. Carvalho, B.M., Guadagnini, D., Tsukumo, D.M., Schenka, A.A., Latuf-Filho, P., Vassallo, J., et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55:10 (2012), 2823–2834.
8. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1031.
9. Velloso, L.A., Folli, F., Saad, M.J., TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation. Endocr Rev 36:3 (2015), 245–271.
10. Caricilli, A.M., Saad, M.J., Gut microbiota composition and its effects on obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 17:4 (2014), 312–318.
11. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:7285 (2010), 59–65.
12. Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489:7415 (2012), 242–249.
13. Duca, F.A., Lam, T.K., Gut microbiota, nutrient sensing and energy balance. Diabetes Obes Metab 16:Suppl. 1 (2014), 68–76.
14. Chow, J., Lee, S.M., Shen, Y., Khosravi, A., Mazmanian, S.K., Host–bacterial symbiosis in health and disease. Adv Immunol 107 (2010), 243–274.
15. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101:44 (2004), 15718–15723.
16. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:6 (2008), 1470–1481.
17. Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50:11 (2007), 2374–2383.
18. Gomes, A.C., Bueno, A.A., de Souza, R.G., Mota, J.F., Gut microbiota, probiotics and diabetes. Nutr J 13 (2014), 1–13.
19. Kootte, R.S., Vrieze, A., Holleman, F., Dallinga-Thie, G.M., Zoetendal, E.G., de Vos, W.M., et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 14:2 (2012), 112–120.
20. Laitinen, K., Poussa, T., Isolauri, E., Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 101:11 (2009), 1679–1687.
21. Chapman, C.M., Gibson, G.R., Rowland, I., Health benefits of probiotics: are mixtures more effective than single strains?. Eur J Nutr 50:1 (2011), 1–17.
22. MacPherson, C.W., Shastri, P., Mathieu, O., Tompkins, T.A., Burguière, P., Genome-wide immune modulation of TLR3-mediated inflammation in intestinal epithelial cells differs between single and multi-strain probiotic combination. PLoS One, 12(1), 2017, e0169847.
23. Ashraf, R., Shah, N.P., Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr 54:7 (2014), 938–956.
24. Kumar, A., Vlasova, A.N., Liu, Z., Chattha, K.S., Kandasamy, S., Esseili, M., et al. In vivo gut transcriptome responses to lactobacillus rhamnosus GG and lactobacillus acidophilus in neonatal gnotobiotic piglets. Gut Microbes 5:2 (2014), 152–164.
25. Fu, Y.R., Yi, Z.J., Pei, J.L., Guan, S., Effects of Bifidobacterium bifidum on adaptive immune senescence in aging mice. Microbiol Immunol 54:10 (2010), 578–583.
26. Hong, M., Kim, S.W., Han, S.H., Kim, D.J., Suk, K.T., Kim, Y.S., et al. Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease. PLoS One, 10(2), 2015, e0117451.
27. Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., et al. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One, 9(1), 2014, e80169.
28. Chen, D., Yang, Z., Chen, X., Huang, Y., Yin, B., Guo, F., et al. Effect of Lactobacillus rhamnosus hsryfm 1301 on the gut microbiota and lipid metabolism in rats fed a high-fat diet. J Microbiol Biotechnol 25:5 (2015), 687–695.
29. Bercik, P., Park, A.J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23:12 (2011), 1132–1139.
30. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., et al. Ingestion of lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108:38 (2011), 16050–16055.
31. Bonaz, B.L., Bernstein, C.N., Brain–gut interactions in inflammatory bowel disease. Gastroenterology 144:1 (2013), 36–49.
32. Smith, C.J., Emge, J.R., Berzins, K., Lung, L., Khamishon, R., Shah, P., et al. Probiotics normalize the gut–brain–microbiota axis in immunodeficient mice. Am J Physiol Gastrointest Liver Physiol, 2014, G793–G802.
33. Schele, E., Grahnemo, L., Anesten, F., Hallen, A., Backhed, F., Jansson, J.O., The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology 154:10 (2013), 3643–3651.
34. Cani, P.D., Joly, E., Horsmans, Y., Delzenne, N.M., Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60:5 (2006), 567–572.
35. Cani, P.D., Knauf, C., How gut microbes talk to organs: the role of endocrine and nervous routes. Mol Metab 5:9 (2016), 743–752.
36. Carvalho-Filho, M.A., Carvalho, B.M., Oliveira, A.G., Guadagnini, D., Ueno, M., Dias, M.M., et al. Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice. Endocrinology 153:11 (2012), 5261–5274.
37. Handschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., Lebrasseur, N.K., et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem 282:41 (2007), 30014–30021.
38. Chakravorty, S., Helb, D., Burday, M., Connell, N., Alland, D., A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. J Microbiol Methods 69:2 (2007), 330–339.
39. Cintra, D.E., Pauli, J.R., Araujo, E.P., Moraes, J.C., de Souza, C.T., Milanski, M., et al. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol 48:4 (2008), 628–637.
40. Quaresma, P.G., Reencober, N., Zanotto, T.M., Santos, A.C., Weissmann, L., de Matos, A.H., et al. Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway. Int J Obes (Lond) 40:1 (2016), 138–146.
41. Martin, T.L., Alquier, T., Asakura, K., Furukawa, N., Preitner, F., Kahn, B.B., Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem 281:28 (2006), 18933–18941.
42. Cho, I., Yamanishi, S., Cox, L., Methe, B.A., Zavadil, J., Li, K., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:7413 (2012), 621–626.
43. Kameyama, K., Itoh, K., Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes Environ 29:4 (2014), 427–430.
44. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:7418 (2012), 55–60.
45. Musso, G., Gambino, R., Cassader, M., Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care 33:10 (2010), 2277–2284.
46. Collado, M.C., Isolauri, E., Laitinen, K., Salminen, S., Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88:4 (2008), 894–899.
47. Schwiertz, A., Taras, D., Schafer, K., Beijer, S., Bos, N.A., Donus, C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18:1 (2010), 190–195.
48. Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:7384 (2012), 179–185.
49. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102:31 (2005), 11070–11075.
50. Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9:5 (2009), 313–323.
51. Martinez, I., Wallace, G., Zhang, C., Legge, R., Benson, A.K., Carr, T.P., et al. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl Environ Microbiol 75:12 (2009), 4175–4184.
52. Serino, M., Luche, E., Gres, S., Baylac, A., Berge, M., Cenac, C., et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61:4 (2012), 543–553.
53. Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannoy, V., Decobecq, M.E., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278:28 (2003), 25481–25489.
54. Holst, J.J., Glucagon and glucagon-like peptides 1 and 2. Results Probl Cell Differ 50 (2010), 121–135.
55. Carvalho, F.A., Aitken, J.D., Vijay-Kumar, M., Gewirtz, A.T., Toll-like receptor-gut microbiota interactions: perturb at your own risk!. Annu Rev Physiol 74 (2012), 177–198.
56. Paz, K., Hemi, R., LeRoith, D., Karasik, A., Elhanany, E., Kanety, H., et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:47 (1997), 29911–29918.
57. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., Spiegelman, B.M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:5249 (1996), 665–668.
58. Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J Clin Invest 116:7 (2006), 1793–1801.
59. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, A.W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:12 (2003), 1796–1808.
60. Furuhashi, M., Tuncman, G., Gorgun, C.Z., Makowski, L., Atsumi, G., Vaillancourt, E., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447:7147 (2007), 959–965.
61. Tilg, H., Hotamisligil, G.S., Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131:3 (2006), 934–945.
62. Morton, G.J., Meek, T.H., Schwartz, M.W., Neurobiology of food intake in health and disease. Nat Rev Neurosci 15:6 (2014), 367–378.
63. Belgardt, B.F., Bruning, J.C., CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 1212 (2010), 97–113.
64. Myers, M.G. Jr., Leibel, R.L., Seeley, R.J., Schwartz, M.W., Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 21:11 (2010), 643–651.
65. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., Flier, J.S., TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:11 (2006), 3015–3025.
66. Lockie, S.H., Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity. J Neuroendocrinol 25:7 (2013), 597–604.